Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors (2015)
- Autores:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1186/s13000-015-0259-3
- Assuntos: DOENÇAS HEMATOLÓGICAS; IMUNOFENOTIPAGEM; CITOMETRIA DE FLUXO; MEDULA ÓSSEA; LEUCEMIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Diabetology & Metabolic Syndrome
- ISSN: 1758-5996
- Volume/Número/Paginação/Ano: v. 10, art. 44, 2015
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
REIS-ALVES, Suiellen C. et al. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors. Diabetology & Metabolic Syndrome, v. 10, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13000-015-0259-3. Acesso em: 19 abr. 2024. -
APA
Reis-Alves, S. C., Traina, F., Metze, K., & Lorand-Metze, I. (2015). Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors. Diabetology & Metabolic Syndrome, 10. doi:10.1186/s13000-015-0259-3 -
NLM
Reis-Alves SC, Traina F, Metze K, Lorand-Metze I. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors [Internet]. Diabetology & Metabolic Syndrome. 2015 ; 10[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/s13000-015-0259-3 -
Vancouver
Reis-Alves SC, Traina F, Metze K, Lorand-Metze I. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors [Internet]. Diabetology & Metabolic Syndrome. 2015 ; 10[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/s13000-015-0259-3 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Hydroxyurea therapy reduces the hypercoagulability state in a sickle cell mouse model
Informações sobre o DOI: 10.1186/s13000-015-0259-3 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
